140 related articles for article (PubMed ID: 26645253)
21. Early grade repetition and inattention associated with neurofibromatosis type 1.
Coudé FX; Mignot C; Lyonnet S; Munnich A
J Atten Disord; 2007 Sep; 11(2):101-5. PubMed ID: 17494836
[TBL] [Abstract][Full Text] [Related]
22. Acute Ischemic Stroke in an Infant With COVID-19 Infection and Delayed Diagnosis of Neurofibromatosis Type 1.
Akbar A; Creeden S
Cureus; 2024 Jan; 16(1):e51524. PubMed ID: 38170086
[TBL] [Abstract][Full Text] [Related]
23. [Anxiety disorders in type 1 neurofibromatosis: A case report].
Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
[TBL] [Abstract][Full Text] [Related]
24. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995-2008.
George MG; Tong X; Kuklina EV; Labarthe DR
Ann Neurol; 2011 Nov; 70(5):713-21. PubMed ID: 21898534
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.
Merker VL; Murphy TP; Hughes JB; Muzikansky A; Hughes MR; Souter I; Plotkin SR
Fertil Steril; 2015 Mar; 103(3):761-8.e1. PubMed ID: 25557241
[TBL] [Abstract][Full Text] [Related]
26. Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.
Liu Q; Zoellner N; Gutmann DH; Johnson KJ
Fam Cancer; 2015 Jun; 14(2):317-24. PubMed ID: 25523354
[TBL] [Abstract][Full Text] [Related]
27. The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnoses.
Tolonen H; Salomaa V; Torppa J; Sivenius J; Immonen-Räihä P; Lehtonen A;
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):380-5. PubMed ID: 17568236
[TBL] [Abstract][Full Text] [Related]
28. Neurofibromatosis type 1 associated with vertebrobasilar dolichoectasia and pontine ischemic stroke.
Giannantoni NM; Broccolini A; Frisullo G; Pilato F; Profice P; Morosetti R; Di Lella G; Zampino G; Della Marca G
J Neuroimaging; 2015; 25(3):505-6. PubMed ID: 25230986
[TBL] [Abstract][Full Text] [Related]
29. Palliative Care Utilization in Nontraumatic Intracerebral Hemorrhage in the United States.
Murthy SB; Moradiya Y; Hanley DF; Ziai WC
Crit Care Med; 2016 Mar; 44(3):575-82. PubMed ID: 26496450
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic drugs and risk of hemorrhagic stroke in the general population.
García-Rodríguez LA; Gaist D; Morton J; Cookson C; González-Pérez A
Neurology; 2013 Aug; 81(6):566-74. PubMed ID: 23843464
[TBL] [Abstract][Full Text] [Related]
31. Cerebral arteriopathy in children with neurofibromatosis type 1.
Rea D; Brandsema JF; Armstrong D; Parkin PC; deVeber G; MacGregor D; Logan WJ; Askalan R
Pediatrics; 2009 Sep; 124(3):e476-83. PubMed ID: 19706560
[TBL] [Abstract][Full Text] [Related]
32. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
[TBL] [Abstract][Full Text] [Related]
33. Speech disorders in neurofibromatosis type 1: a sample survey.
Cosyns M; Vandeweghe L; Mortier G; Janssens S; Van Borsel J
Int J Lang Commun Disord; 2010; 45(5):600-7. PubMed ID: 19900076
[TBL] [Abstract][Full Text] [Related]
34. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
Lorenzo J; Barton B; Arnold SS; North KN
J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
[TBL] [Abstract][Full Text] [Related]
35. Stroke in young adults: a retrospective analysis.
Banet GA
J Vasc Nurs; 1994 Dec; 12(4):101-5. PubMed ID: 7888381
[TBL] [Abstract][Full Text] [Related]
36. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of neurofibromatosis type 1 in the Finnish population.
Kallionpää RA; Uusitalo E; Leppävirta J; Pöyhönen M; Peltonen S; Peltonen J
Genet Med; 2018 Sep; 20(9):1082-1086. PubMed ID: 29215653
[TBL] [Abstract][Full Text] [Related]
38. Social functioning in adults with neurofibromatosis type 1.
Pride NA; Crawford H; Payne JM; North KN
Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
[TBL] [Abstract][Full Text] [Related]
39. Transient ischemic attack and minor stroke are the most common manifestations of acute cerebrovascular disease: a prospective, population-based study--the Aarhus TIA study.
von Weitzel-Mudersbach P; Andersen G; Hundborg HH; Johnsen SP
Neuroepidemiology; 2013; 40(1):50-5. PubMed ID: 23075482
[TBL] [Abstract][Full Text] [Related]
40. Associations of clinical features in neurofibromatosis 1 (NF1).
Szudek J; Birch P; Riccardi VM; Evans DG; Friedman JM
Genet Epidemiol; 2000 Dec; 19(4):429-39. PubMed ID: 11108651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
